Vaccine Information Statements |
|
|
|
|
|
| |
|
|
| |
Up-to-date
translations |
|
|
|
| You are encouraged to distribute the up-to-date
English-language version at the same time as the translation. |
|
|
|
|
|
|
| |
Out-of-date translations |
|
|
|
| The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current
English-language version of the following VISs. |
|
|
| TRANSLATION OF THE JANUARY 28, 2008 MENINGOCOCCAL VIS |
|
|
|
|
|
|
| This translation does not contain
the following CDC update: |
|
| • |
|
It incorporates changes in the routine schedule and indications, as well as in the precautions and adverse events sections. Healthcare providers should begin using the new VIS as soon as possible. |
|
|
|
| TRANSLATIONS OF THE MARCH 31, 2000 MENINGOCOCCAL VIS |
|
|
|
|
| |
|
| This translation does not
contain the following CDC updates: |
|
| • |
|
The Guillain-Barre Syndrome (second bullet just above section 6) was changed slightly: "a few" was replaced by "some" to reflect the additional cases that were reported. |
|
|
|
| • |
|
Section 5: Under severe problems, CDC added information about a possible connection to Guillain-Barre Syndrome. |
|
|
|
| • |
|
Section 1: CDC changed the words to say, "Of those who live, another 11%-19% lose their arms or legs..." |
|
|
|
| • |
|
Section 3: There are new recommendations for MCV4. CDC has added that meningococcal vaccine is recommended for college freshman living in dormitories and microbiologists who are routinely exposed to meningococcal bacteria. |
|
|
|
| • |
|
Section 4: It says MCV4 is a new vaccine that has not been studied in pregnant women as much as MPSV4 has. |
|
|
|
| • |
|
Section 5: There is some more information about MCV4. |
|
A-Z
